Our Clinical Trial Experience With Chikungunya Virus

CHIKV outbreaks have occurred in countries in Africa, Asia, Europe, and the Indian and Pacific Oceans. It was found for the first time in the Americas on islands in the Caribbean in 2013 and has spread throughout most of the Americas. It has since been identified in over 60 countries in Asia, Africa, Europe and the Americas. No commercially available vaccine to prevent or medicine to treat CHIKV infection is currently available.
Our Clinical Trial Experience With Chikungunya Virus

Related Resources

Brochure

Vaccine Development

Webinar

Africa’s Potential for Clinical Research

Video

Global Vaccine Development

Brochure

Full-Service Global Support for COVID-19 Studies

Indication Overview

Our Clinical Trial Experience With Malaria

Brochure

Our Experience in sub-Saharan Africa

Webinar

Follow the Epi: Finding TB-Prevalent Populations to Guide TB Vaccine Protocol Design

Video

We Have Long-Standing Relationships